Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M757Revenue $M47.8Net Margin (%)-213.2Z-Score-6.4
Enterprise Value $M738EPS $-1.3Operating Margin %-182.9F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-212.8Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsY
Price/Sales13.45-y EBITDA Growth Rate %0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-91.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)6ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M103ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with MACK

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

MACK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-08-26Sell24,000$6.875.68 view
CROCKER GARY LDirector 2014-06-23Buy36,000$6.846.14 view
PORTER MICHAEL EDirector 2014-06-23Buy32,390$6.846.14 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-05-27Sell16,000$8-9.25 view
Nielsen Ulrik B.SVP and CSO 2014-05-27Sell105,000$8.01-9.36 view
CROCKER GARY LDirector 2014-05-20Buy4,000$6.698.52 view
Quigley James H.Director 2014-05-19Buy5,000$6.5810.33 view
CROCKER GARY LDirector 2014-05-19Buy9,400$6.688.68 view
PORTER MICHAEL EDirector 2014-05-16Buy15,000$6.4911.86 view
Sinskey Anthony JDirector 2014-05-13Buy5,000$6.747.72 view

Press Releases about MACK :

    Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Sep 15 2014
    5 Stocks Under $10 Soaring Higher Sep 12 2014
    Market Has Not Yet Noticed Potential in Merrimack Pharmaceuticals (MACK); Have You? Sep 10 2014
    Can Merrimack Pharmaceuticals (MACK) Run Higher on Strong Earnings Estimate Revisions? Sep 09 2014
    Is Merrimack Pharmaceuticals (MACK) Stock a Solid Choice Right Now? Aug 28 2014
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 11 2014
    Q2 2014 Merrimack Pharmaceuticals Inc Earnings Release - Before Market Open Aug 11 2014
    Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients... Aug 11 2014
    Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results Aug 11 2014
    Merrimack Pharmaceuticals Announces Timing of Second Quarter 2014 Investor Conference Call Aug 04 2014
    Is Now The Time To Buy Merrimack Pharmaceuticals? Jul 08 2014
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jun 30 2014
    Key Stocks With Insider Buying This Week Jun 28 2014
    Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress... Jun 25 2014
    5 Stocks With Big Insider Buying Jun 25 2014
    Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights Jun 23 2014
    Merrimack Pharmaceuticals (MACK) Crumbles: Stock Tanks by 11.3% Jun 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial